Last updated: 2026-09-16 10:31:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Lifecore Biomedical, Inc. (LFCR) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $4,14, with a market capitalisation of $160,88M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3,63 to $8,98. This page covers its latest market performance, valuation, price trends and company information.
$160,88M | |
$4,21 | |
$11,46 | |
$1,52 | |
$4,25 | |
52,16K | |
171,19K | |
-- | |
$8,98 | |
$3,63 | |
-- | |
-- |
Lifecore Biomedical, Inc. (LFCR) is trading at $4,08 in pre-market trading as of 2026-09-15 23:31:00, down 4,00% ($0,17) from the previous close of $4,25
Pre-market trading shows how investors are pricing LFCR before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, Lifecore Biomedical, Inc. (LFCR) moved from $4,40 to $4,14, representing a decline of 5,82% ($0,26).
The stock traded between $4,00 and $4,60 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 181,92 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 9,7%
LFCR is currently trading at $4,14, placing it 9,7% of the way from its 52-week low of $3,63 to its 52-week high of $8,98. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 382 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Lifecore Biomedical, Inc. (LFCR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.